Text Size

Diffusion and Protein Corona Formation of Lipid-Based Nanoparticles in the Vitreous Humor: Profiling and Pharmacokinetic Considerations

Tavakoli S., Kari O.K., Turunen T., Lajunen T., Schmitt M., Lehtinen J., Tasaka F., Parkkila P., Ndika J., Viitala T., Alenius H., Urtti A., Subrizi A.


  • 2021
  • Molecular Pharmaceutics
View publication
  • Therapeutic Area

    Back of the eye (BOTE)

  • Technology

    Pharmacology

  • Affiliations

    Tavakoli, S., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Kari, O.K., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Turunen, T., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Lajunen, T., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Schmitt, M., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Lehtinen, J., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Tasaka, F., Pharmaceutics and Pharmacology Department, Global Rand, Santen Pharmaceutical Co., Ltd., 8916-16 Takayama-cho, Ikoma, Nara, 630-0101, Japan; Parkkila, P., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Ndika, J., Human Microbiome Research, Faculty of Medicine, University of Helsinki, P.O. Box 21, Helsinki, 00290, Finland; Viitala, T., Division of Pharmaceutical Chemistry and Technology, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland; Alenius, H., Human Microbiome Research, Faculty of Medicine, University of Helsinki, P.O. Box 21, Helsinki, 00290, Finland, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 171 77, Sweden; Urtti, A., Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, Helsinki, 00014, Finland, Institute of Chemistry, St. Petersburg State University, Petergof, Universitetskii pr. 26, St. Petersburg, 198504, Russian Federation, School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, Kuopio, 70210, Finland; Subrizi, A., School of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, Yliopistonranta 1, Kuopio, 70210, Finland

Related Publications

Economic evaluation, resource utilisation, and associated economic burden of myopia management: a systematic literature review

de Milliano T. WL, Shi-van Wielink K., Ernst F., Mulkalapalli N., Pagidigummula R., Lymperopoulou C.


Efficacy and Safety of Low-Concentration Atropine in Slowing Myopia Progression in Children in Japan: The Randomized, Double-Blind Phase II/III ORANGE Study

Ohno-Matsui K., Igarashi-Yokoi T., Migita Y., Yamakawa Y, on behalf of the ORANGE study investigators


Awareness of Myopia Associated Complications and Perspectives on Myopia Management Among Parents of Children with Myopia in France and the UK

Hafizi R., Deferne N., Paudel N., Angerer A., Hsieh H.-T.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022